Your browser doesn't support javascript.
loading
High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.
Crombé, Amandine; Le Loarer, François; Cornelis, François; Stoeckle, Eberhardt; Buy, Xavier; Cousin, Sophie; Italiano, Antoine; Kind, Michèle.
Afiliação
  • Crombé A; Department of Diagnostic and Interventional Radiology, Institut Bergonie, Comprehensive Cancer Center, 229 cours de l'Argonne, F-33000, Bordeaux, France. amandine.crombe@ens-lyon.fr.
  • Le Loarer F; Modelisation in Oncology (MOnc) Team, INRIA Bordeaux-Sud-Ouest, CNRS UMR 5251 & Université de Bordeaux, F-33405, Talence, France. amandine.crombe@ens-lyon.fr.
  • Cornelis F; University of Bordeaux, F-33000, Bordeaux, France. amandine.crombe@ens-lyon.fr.
  • Stoeckle E; University of Bordeaux, F-33000, Bordeaux, France.
  • Buy X; Department of Pathology, Institut Bergonie, F-33000, Bordeaux, France.
  • Cousin S; Department of Radiology, Tenon Hospital, Sorbonne University, APHP, F-75020, Paris, France.
  • Italiano A; Department of Surgery, Institut Bergonie, F-33000, Bordeaux, France.
  • Kind M; Department of Diagnostic and Interventional Radiology, Institut Bergonie, Comprehensive Cancer Center, 229 cours de l'Argonne, F-33000, Bordeaux, France.
Eur Radiol ; 29(2): 545-555, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30039222
ABSTRACT

OBJECTIVES:

To determine the acquisition delay after gadolinium-chelate injection that optimizes the prediction of the histological response during anthracycline-based neoadjuvant chemotherapy (NAC) for locally advanced high-grade soft-tissue sarcomas (STS).

METHODS:

Thirty patients (mean age 62 years) were included in this IRB-approved study. All patients received 5-6 cycles of NAC followed by surgery. A good response was defined as ≤ 10% viable cells on histological analysis of the surgical specimen. DCE-MRI was performed before treatment (MRI0) and after two cycles (MRI1). Images were obtained every 8 s. Change in contrast enhancement (CE) between MRI0 and MRI1 was calculated for each acquisition delay 't' on the whole tumor volume. Area under the receiver-operating characteristics curves (AUROC) for change in CE was calculated at each acquisition delay, as well as the accuracy of the Choi criteria.

RESULTS:

There were 22 (73.3%) poor responders. Acquisition delay had a significant effect on change in CE and on the response status according to Choi (p = 0.0014 and 0.0270, respectively). The highest AUROC was obtained at t = 58 s (0.792) with an optimal threshold of a -30.5% decrease in CE. At t = 58 s, accuracy to predict a poor response was 82.8% above this threshold, while it was 72.4% and 70% with no objective response according to the Choi criteria and RECIST1.1, respectively.

CONCLUSION:

Optimization of acquisition delay after injection to estimate change in CE improves the prediction of histological response. For STS undergoing NAC, a 60-s delay can be recommended with MRI. KEY POINTS • Accuracy of response criteria based on contrast enhancement, like the Choi criteria, is dependent on the acquisition delay after gadolinium-chelate injection. • DCE-MRI helps determine the optimal acquisition delay after gadolinium-chelate injection for improving evaluation of tumor response. • In soft tissue sarcoma, an acquisition delay at 60 s optimizes the evaluation of the response and accuracy of the Choi criteria.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article